Compare APGE & CACC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APGE | CACC |
|---|---|---|
| Founded | 2022 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 5.2B |
| IPO Year | 2023 | 1996 |
| Metric | APGE | CACC |
|---|---|---|
| Price | $83.66 | $424.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 1 |
| Target Price | $109.67 | ★ $470.00 |
| AVG Volume (30 Days) | ★ 1.1M | 203.4K |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.00 |
| EPS | N/A | ★ 36.38 |
| Revenue | N/A | ★ $2,317,200,000.00 |
| Revenue This Year | N/A | $91.73 |
| Revenue Next Year | N/A | $3.58 |
| P/E Ratio | ★ N/A | $11.53 |
| Revenue Growth | N/A | ★ 7.16 |
| 52 Week Low | $26.20 | $401.90 |
| 52 Week High | $85.94 | $549.75 |
| Indicator | APGE | CACC |
|---|---|---|
| Relative Strength Index (RSI) | 63.82 | 35.48 |
| Support Level | $73.06 | $406.44 |
| Resistance Level | N/A | $522.77 |
| Average True Range (ATR) | 4.54 | 20.20 |
| MACD | 1.27 | -2.97 |
| Stochastic Oscillator | 90.56 | 25.76 |
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.